President Donald Trump declared Monday that the U.S. “will no longer tolerate profiteering and price gouging from Big Pharma” as he signed an executive order implementing what his administration is calling “most favored nations drug pricing.” 

“The principle is simple – whatever the lowest price paid for a drug in other developed countries, that is the price that Americans will pay,” Trump said at the White House. “Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%.” 

Trump said that “starting today, the United States will no longer subsidize the healthcare of foreign countries, which is what we were doing. We’re subsidizing others’ healthcare, the countries where they paid a small fraction of what for the same drug that what we pay many, many times more for and will no longer tolerate profiteering and price gouging from Big Pharma.” 

“Even though the United States is home to only 4% of the world’s population, pharmaceutical companies make more than two thirds of their profits in America. So think of that with 4% of the population, the pharmaceutical companies make most of their money. Most of their profits from America. That’s not a good thing,” Trump continued.  

TRUMP SAYS HE WILL SLASH DRUG PRICES WITH EXECUTIVE ORDER

“I think, by the way, pharmaceutical – I have great respect for these companies and for the people that run them. I really do, and I think they did one of the greatest jobs in history for their company, convincing people for many years that this was a fair system. Nobody really understood why, but I figured it out. For years, pharmaceutical and drug companies have said that research and development costs were what they are, and for no reason whatsoever, they had to be borne by America alone,” Trump said. “Not anymore, they don’t.” 

The White House said the executive order “directs the U.S. Trade Representative and Secretary of Commerce to take action to ensure foreign countries are not engaged in practices that purposefully and unfairly undercut market prices and drive price hikes in the United States.

“The Order instructs the Administration to communicate price targets to pharmaceutical manufacturers to establish that America, the largest purchaser and funder of prescription drugs in the world, gets the best deal,” the White House said.

“The Secretary of Health and Human Services will establish a mechanism through which American patients can buy their drugs directly from manufacturers who sell to Americans at a ‘Most-Favored-Nation’ price, bypassing middlemen,” the White House added. “If drug manufacturers fail to offer most-favored-nation pricing, the Order directs the Secretary of Health and Human Services to: (1) propose rules that impose most-favored-nation pricing; and (2) take other aggressive measures to significantly reduce the cost of prescription drugs to the American consumer and end anticompetitive practices.”

Robert F. Kennedy Jr., the U.S. Secretary of Health and Human Services, said alongside Trump, “I never thought that this would happen in my lifetime.”

“I have a couple of kids who are Democrats, are big Bernie Sanders fans. And when I told them that this was going to happen, they had tears in their eyes. Because they thought, this is never going to happen,” he said. “And we finally have a president who is willing to stand up for the American people.” 

MAHA CAUCUS MEMBER PLEDGES HEARINGS INTO ‘CORRUPTION’ OF A PUBLIC HEALTH SECTOR ‘CAPTURED BY BIG PHARMA’

Bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J., in July 2018. (AP/Julio Cortez)

Trump said earlier this morning that drug prices would be “cut by 59%.” 

The Pharmaceutical Research and Manufacturers of America (PhRMA) trade group opposes the order, saying, “This Foreign First Pricing scheme is a bad deal for American patients.” 

“Importing foreign prices will cut billions of dollars from Medicare with no guarantee that it helps patients or improves their access to medicines,” the group’s president, Stephen Ubl, said in a statement provided to Fox News Digital. “It will jeopardize the hundreds of billions our member companies are planning to invest in America, making us more reliant on China for innovative medicines.” 

President Donald Trump signs executive orders in the Oval Office of the White House on Jan. 20, in Washington, D.C. (Anna Moneymaker/Getty Images)

“To lower costs for Americans, we need to address the real reasons U.S. patients are paying more for their medicines. We are the only country in the world that lets PBMs, insurers and hospitals take 50% of every dollar spent on medicines,” Ubl also said. “In fact, hospital markups in 340B and the rebates and fees paid to middlemen in the U.S. often exceed the total cost of medicines oversees. Giving more of this money to patients will lower their medicine costs and reduce the gap with European prices.” 

Fox News Digital’s Greg Wehner contributed to this report.  

The Trump administration announced Monday that it has launched an investigation into California’s Cash Assistance Program for Immigrants, a state program that provides monthly cash benefits to aged, blind, and disabled non-citizens who are ineligible for Social Security benefits due to their immigration status.

The investigation began in Los Angeles, with Immigration and Customs Enforcement’s Homeland Security Investigations Los Angeles field office issuing a Title 8 subpoena to California’s Cash Assistance Program for Immigrants, the Department of Homeland Security said in a news release.

According to the department, the subpoena requests all records from the Los Angeles County Department of Public Social Services, the agency that administers the state program, to determine if ineligible immigrants received supplemental security income from the Social Security Administration over the last four years.

“Radical left politicians in California prioritize illegal aliens over our own citizens, including by giving illegal aliens access to cash benefits,” Homeland Security Secretary Kristi Noem said in a statement.

“The Trump Administration is working together to identify abuse and exploitation of public benefits and make sure those in this country illegally are not receiving federal benefits or other financial incentives to stay illegally,” Noem added. “If you are an illegal immigrant, you should leave now. The gravy train is over. While this subpoena focuses only on Los Angeles County — it is just the beginning.”

According to Homeland Security, its Los Angeles investigations field office is subpoenaing records including applicants’ name and date of birth, copies of applications, immigration status, proof of ineligibility for benefits from the Social Security Administration and affidavits that supported the application.

The investigation comes after President Trump signed a presidential memorandum on April 15 to stop immigrants lacking documentation from obtaining Social Security Act benefits in what he called a bid to stop incentivizing illegal immigration and protect taxpayer dollars.

The memorandum directed the secretary of Homeland Security to ensure unauthorized immigrants do not receive funds from Social Security programs and prioritized civil or criminal enforcement against states or localities for potential violations of Title IV of the Personal Responsibility and Work Opportunity Reconciliation Act.

It also expanded the Social Security Administration’s fraud prosecutor program to at least 50 U.S. attorney ofices and established a Medicare and Medicaid fraud-prosecution program in 15 U.S. attorney offices.

This is a developing story and will be updated.

Mr. Luers doubled the museum’s endowment, modernized its financial systems, enlarged its staff to 1,800 full-time employees, secured the $1 billion Walter Annenberg collection of French Impressionist and Post-Impressionist paintings for the museum, and oversaw the construction of new galleries, wings, exhibitions and public programs. When he stepped down, the museum had a $116 million budget, and crowds that often exceeded 50,000 visitors on weekends.

In 1990, Mr. Luers arranged for Mr. Havel, who was conferring with President George W. Bush on a state visit to the White House, to make a side trip to New York to visit the museum. It was a touching reunion for Mr. Luers, who returned many times to the Czech Republic for meetings with old friends and Mr. Havel, who died in 2011.

After the Met, Mr. Luers was chairman and president of the United Nations Association of the U.S.A., which provides research and other services for the U.N. For many years, he also directed the Iran Project, a nongovernmental organization that supported United States negotiations with Iran.

Mr. Luers, who had homes in Manhattan and Washington Depot, wrote scores of articles for foreign policy journals and newspapers, including The Times. He lectured widely and taught at Princeton, George Washington, Columbia and Seton Hall Universities, and at the School of Advanced International Studies at Johns Hopkins University. Last fall, he released a memoir, “Uncommon Company: Dissidents and Diplomats, Enemies and Artists.”

“My greatest satisfaction was the success of Vaclav Havel,” he said in the 2022 interview. “Havel proved my point that culture makes a difference, especially in international relations. The Communist system was deeply flawed. It underestimated cultural leaders’ influence on the people.”

Alex Traub contributed reporting.